These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 24050928)

  • 21. Aggressive pituitary adenomas occurring in young patients in a large Polynesian kindred with a germline R271W mutation in the AIP gene.
    Jennings JE; Georgitsi M; Holdaway I; Daly AF; Tichomirowa M; Beckers A; Aaltonen LA; Karhu A; Cameron FJ
    Eur J Endocrinol; 2009 Nov; 161(5):799-804. PubMed ID: 19684062
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Low frequency of AIP mutations in patients with young-onset sporadic pituitary macroadenomas.
    Gaspar LM; Gonçalves CI; Saraiva C; Cortez L; Amaral C; Nobre E; Lemos MC
    J Endocrinol Invest; 2023 Nov; 46(11):2299-2307. PubMed ID: 37149543
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A novel truncating AIP mutation, p.W279*, in a familial isolated pituitary adenoma (FIPA) kindred.
    Cansu GB; Taşkıran B; Trivellin G; Faucz FR; Stratakis CA
    Hormones (Athens); 2016 Jul; 15(3):441-444. PubMed ID: 27838609
    [TBL] [Abstract][Full Text] [Related]  

  • 24. High prevalence of AIP gene mutations following focused screening in young patients with sporadic pituitary macroadenomas.
    Tichomirowa MA; Barlier A; Daly AF; Jaffrain-Rea ML; Ronchi C; Yaneva M; Urban JD; Petrossians P; Elenkova A; Tabarin A; Desailloud R; Maiter D; Schürmeyer T; Cozzi R; Theodoropoulou M; Sievers C; Bernabeu I; Naves LA; Chabre O; Montañana CF; Hana V; Halaby G; Delemer B; Aizpún JI; Sonnet E; Longás AF; Hagelstein MT; Caron P; Stalla GK; Bours V; Zacharieva S; Spada A; Brue T; Beckers A
    Eur J Endocrinol; 2011 Oct; 165(4):509-15. PubMed ID: 21753072
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Low rate of germline AIP mutations in patients with apparently sporadic pituitary adenomas before the age of 40: a single-centre adult cohort.
    Preda V; Korbonits M; Cudlip S; Karavitaki N; Grossman AB
    Eur J Endocrinol; 2014 Nov; 171(5):659-66. PubMed ID: 25184284
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Germline AIP variants in sporadic young acromegaly and pituitary gigantism: clinical and genetic insights from a Han Chinese cohort.
    Xiang B; Zhang X; Liu W; Mao B; Zhao Y; Wang Y; Gong W; Ye H; Li Y; Zhang Z; Yu Y; He M
    Endocrine; 2024 Sep; 85(3):1346-1356. PubMed ID: 38851643
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Characterization of aryl hydrocarbon receptor interacting protein (AIP) mutations in familial isolated pituitary adenoma families.
    Igreja S; Chahal HS; King P; Bolger GB; Srirangalingam U; Guasti L; Chapple JP; Trivellin G; Gueorguiev M; Guegan K; Stals K; Khoo B; Kumar AV; Ellard S; Grossman AB; Korbonits M;
    Hum Mutat; 2010 Aug; 31(8):950-60. PubMed ID: 20506337
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Germline inactivating mutations of the aryl hydrocarbon receptor-interacting protein gene in a large cohort of sporadic acromegaly: mutations are found in a subset of young patients with macroadenomas.
    Cazabat L; Libè R; Perlemoine K; René-Corail F; Burnichon N; Gimenez-Roqueplo AP; Dupasquier-Fediaevsky L; Bertagna X; Clauser E; Chanson P; Bertherat J; Raffin-Sanson ML
    Eur J Endocrinol; 2007 Jul; 157(1):1-8. PubMed ID: 17609395
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Large genomic deletions in AIP in pituitary adenoma predisposition.
    Georgitsi M; Heliövaara E; Paschke R; Kumar AV; Tischkowitz M; Vierimaa O; Salmela P; Sane T; De Menis E; Cannavò S; Gündogdu S; Lucassen A; Izatt L; Aylwin S; Bano G; Hodgson S; Koch CA; Karhu A; Aaltonen LA
    J Clin Endocrinol Metab; 2008 Oct; 93(10):4146-51. PubMed ID: 18628514
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The clinical, pathological, and genetic features of familial isolated pituitary adenomas.
    Beckers A; Daly AF
    Eur J Endocrinol; 2007 Oct; 157(4):371-82. PubMed ID: 17893250
    [TBL] [Abstract][Full Text] [Related]  

  • 31.
    Trofimiuk-Müldner M; Domagała B; Sokołowski G; Skalniak A; Hubalewska-Dydejczyk A
    Front Endocrinol (Lausanne); 2023; 14():1098367. PubMed ID: 36843582
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mutations in the aryl hydrocarbon receptor interacting protein gene are not highly prevalent among subjects with sporadic pituitary adenomas.
    Barlier A; Vanbellinghen JF; Daly AF; Silvy M; Jaffrain-Rea ML; Trouillas J; Tamagno G; Cazabat L; Bours V; Brue T; Enjalbert A; Beckers A
    J Clin Endocrinol Metab; 2007 May; 92(5):1952-5. PubMed ID: 17299063
    [TBL] [Abstract][Full Text] [Related]  

  • 33. AIP mutations and gigantism.
    Rostomyan L; Potorac I; Beckers P; Daly AF; Beckers A
    Ann Endocrinol (Paris); 2017 Jun; 78(2):123-130. PubMed ID: 28483363
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Frequency of familial pituitary adenoma syndromes among patients with functioning pituitary adenomas in a reference outpatient clinic.
    Marques NV; Kasuki L; Coelho MC; Lima CHA; Wildemberg LE; Gadelha MR
    J Endocrinol Invest; 2017 Dec; 40(12):1381-1387. PubMed ID: 28689311
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [AIP mutations in familial and sporadic pituitary adenomas: local experience and review of the literature].
    Fajardo-Montañana C; Daly AF; Riesgo-Suárez P; Gómez-Vela J; Tichomirowa MA; Camara-Gómez R; Beckers A
    Endocrinol Nutr; 2009; 56(7):369-77. PubMed ID: 19883897
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pituitary adenoma predisposition caused by germline mutations in the AIP gene.
    Vierimaa O; Georgitsi M; Lehtonen R; Vahteristo P; Kokko A; Raitila A; Tuppurainen K; Ebeling TM; Salmela PI; Paschke R; Gündogdu S; De Menis E; Mäkinen MJ; Launonen V; Karhu A; Aaltonen LA
    Science; 2006 May; 312(5777):1228-30. PubMed ID: 16728643
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical experience in the screening and management of a large kindred with familial isolated pituitary adenoma due to an aryl hydrocarbon receptor interacting protein (AIP) mutation.
    Williams F; Hunter S; Bradley L; Chahal HS; Storr HL; Akker SA; Kumar AV; Orme SM; Evanson J; Abid N; Morrison PJ; Korbonits M; Atkinson AB
    J Clin Endocrinol Metab; 2014 Apr; 99(4):1122-31. PubMed ID: 24423289
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Aryl hydrocarbon receptor interacting protein (AIP) mutations occur rarely in sporadic parathyroid adenomas.
    Pardi E; Marcocci C; Borsari S; Saponaro F; Torregrossa L; Tancredi M; Raspini B; Basolo F; Cetani F
    J Clin Endocrinol Metab; 2013 Jul; 98(7):2800-10. PubMed ID: 23633209
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Familial isolated pituitary adenomas (FIPA) and mutations in the aryl hydrocarbon receptor interacting protein (AIP) gene.
    Daly AF; Beckers A
    Endocrinol Metab Clin North Am; 2015 Mar; 44(1):19-25. PubMed ID: 25732638
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Familial acromegaly due to aryl hydrocarbon receptor-interacting protein (AIP) gene mutation in a Turkish cohort.
    Niyazoglu M; Sayitoglu M; Firtina S; Hatipoglu E; Gazioglu N; Kadioglu P
    Pituitary; 2014 Jun; 17(3):220-6. PubMed ID: 23743763
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.